Company profile for Trefoil Therapeutics

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Trefoil is a biotechnology company focused on leveraging its engineered fibroblast growth factor-1 protein (eFGF-1) technology platform to develop first-in-class regenerative pharmacologic treatments for corneal diseases, which are debilitating and cause a significant amount of preventable blindness throughout the world. Lead candidate TTHX1114 is an engineered form of FGF-1 designed to stimulate proliferation and migration...
Trefoil is a biotechnology company focused on leveraging its engineered fibroblast growth factor-1 protein (eFGF-1) technology platform to develop first-in-class regenerative pharmacologic treatments for corneal diseases, which are debilitating and cause a significant amount of preventable blindness throughout the world. Lead candidate TTHX1114 is an engineered form of FGF-1 designed to stimulate proliferation and migration of corneal endothelial cells. It is initially being developed as an intracameral injection as the first pharmacologic treatment for back of the cornea surface disease (endothelial dystrophy).

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
11189 Sorrento Valley Road Suite 104 San Diego, CA 92121 ​
Telephone
Telephone
858.224.3356
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

BePharma

Not Confirmed

envelop Contact Supplier

BePharma

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.businesswire.com/news/home/20230508005258/en

BUSINESSWIRE
08 May 2023

https://www.businesswire.com/news/home/20230424005334/en

BUSINESSWIRE
24 Apr 2023

https://www.businesswire.com/news/home/20230417005224/en

BUSINESSWIRE
17 Apr 2023

https://www.clinicaltrialsarena.com/news/trefoil-corneal-epithelial-defects/

CLINICAL TRIALS ARENA
19 Jan 2023

https://www.businesswire.com/news/home/20230118005068/en

BUSINESSWIRE
18 Jan 2023

https://www.businesswire.com/news/home/20220929005034/en

BUSINESSWIRE
29 Sep 2022

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty